[Federal Register Volume 89, Number 174 (Monday, September 9, 2024)]
[Notices]
[Page 73124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20193]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1423]


Bulk Manufacturer of Controlled Substances Application: Curia New 
York, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Curia New York, Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
November 8, 2024. Such persons may also file a written request for a 
hearing on the application on or before November 8, 2024.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 6, 2024, Curia New York, Inc., 33 Riverside 
Avenue, Rensselaer, New York 12144-2951, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
            Controlled substance                Drug code      Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..................            2010            I
Marihuana..................................            7360            I
Tetrahydrocannabinols......................            7370            I
Amphetamine................................            1100           II
Lisdexamfetamine...........................            1205           II
Methylphenidate............................            1724           II
Pentobarbital..............................            2270           II
4-Anilino-N-Phenethyl-4-Piperidine (ANPP)..            8333           II
Codeine....................................            9050           II
Oxycodone..................................            9143           II
Hydromorphone..............................            9150           II
Hydrocodone................................            9193           II
Meperidine.................................            9230           II
Morphine...................................            9300           II
Fentanyl...................................            9801           II
------------------------------------------------------------------------

    The company plans to manufacture the above listed controlled 
substances as bulk active pharmaceutical ingredients for use in product 
development and for distribution to its customers.
    In reference to drug codes 7360 (Marihuana), and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-20193 Filed 9-6-24; 8:45 am]
BILLING CODE P